Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
Ionis Pharmaceuticals(IONS) stock is priced at $76.50, giving the company a market capitalization of 12.64B. It carries a P/E multiple of -36.39.
As of 2026-05-30, Ionis Pharmaceuticals(IONS) stock has fluctuated between $76.39 and $78.10. The current price stands at $76.50, placing the stock +0.1% above today's low and -2.0% off the high.
Ionis Pharmaceuticals(IONS) shares are trading with a volume of 1.67M, against a daily average of 1.76M.
During the past year, Ionis Pharmaceuticals(IONS) stock moved between $32.55 at its lowest and $86.74 at its peak.
During the past year, Ionis Pharmaceuticals(IONS) stock moved between $32.55 at its lowest and $86.74 at its peak.
IONS News
In a report released yesterday, Gary Nachman from Canaccord Genuity maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $110.00. Unlock tr...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced data for bepirovirsen, an investigational antisense oligonucleotide for the treatment of chronic hepati...
Analyst ratings
88%
of 26 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.